Latest Headlines

October 30, 2026

FDA approves tildrakizumab for psoriatic arthritis

The IL-23 inhibitor gains a new indication after 2 phase 3 trials show improved joint responses versus placebo.

MDSpire News

October 27, 2026

AMD incidence may be higher in lupus

A nationwide Korean cohort found elevated AMD rates among patients with SLE, without a corresponding increase with treatment-defined disease severity.

MDSpire News

October 23, 2026

Lupus nephritis may remit despite HIV

A patient with biopsy-confirmed renal disease achieved remission during immunosuppressive therapy while maintaining stable HIV control.

MDSpire News

October 21, 2026

FDA approves liquid cevimeline for Sjögren disease

The new oral solution offers an alternative to capsules for adults with dry mouth, including those with swallowing difficulties.

MDSpire News

October 19, 2026

Targeting bone marrow pathway may curb bone loss

Researchers identify a pathway connecting bone marrow fat accumulation, inflammation, and impaired bone formation, with combined treatment preserving skeletal structure in aging mice.

MDSpire News